Atıf Formatları
Tamoxifen in breast cancer survivors with COVID 19: stop or go?
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

C. Karacin Et Al. , "Tamoxifen in breast cancer survivors with COVID 19: stop or go?," MEDICAL ONCOLOGY , vol.38, no.4, 2021

Karacin, C. Et Al. 2021. Tamoxifen in breast cancer survivors with COVID 19: stop or go?. MEDICAL ONCOLOGY , vol.38, no.4 .

Karacin, C., Karacin, P., & Ergun, Y., (2021). Tamoxifen in breast cancer survivors with COVID 19: stop or go?. MEDICAL ONCOLOGY , vol.38, no.4.

Karacin, Cengiz, Pinar Karacin, And Yakup Ergun. "Tamoxifen in breast cancer survivors with COVID 19: stop or go?," MEDICAL ONCOLOGY , vol.38, no.4, 2021

Karacin, Cengiz Et Al. "Tamoxifen in breast cancer survivors with COVID 19: stop or go?." MEDICAL ONCOLOGY , vol.38, no.4, 2021

Karacin, C. Karacin, P. And Ergun, Y. (2021) . "Tamoxifen in breast cancer survivors with COVID 19: stop or go?." MEDICAL ONCOLOGY , vol.38, no.4.

@article{article, author={Cengiz Karacin Et Al. }, title={Tamoxifen in breast cancer survivors with COVID 19: stop or go?}, journal={MEDICAL ONCOLOGY}, year=2021}